Post-approval studies (Phase 4)Study completedNCT03970044
What this trial is testing
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Who this might be right for
Diabetes Mellitus, Type 2
Consano Clinical Research, LLC 67